Showing 2 posts of 2 posts found.
A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …
GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO